These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1953789)

  • 1. The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa.
    Gartner TK; Loudon R; Taylor DB
    Biochem Biophys Res Commun; 1991 Nov; 180(3):1446-52. PubMed ID: 1953789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The amino acid sequence Gly-Ala-Pro-Leu appears to be a fibrinogen binding site in the platelet integrin, glycoprotein IIb.
    Gartner TK; Taylor DB
    Thromb Res; 1990 Nov; 60(4):291-309. PubMed ID: 1708172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to GPIIb alpha (300-312) inhibit Fg binding, clot retraction, and platelet adhesion to multiple ligands.
    Taylor DB; Derrick JM; Gartner TK
    Proc Soc Exp Biol Med; 1994 Jan; 205(1):35-43. PubMed ID: 7509487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peptide Glu-His-Ile-Pro-Ala binds fibrinogen and inhibits platelet aggregation and adhesion to fibrinogen and vitronectin.
    Gartner TK; Taylor DB
    Proc Soc Exp Biol Med; 1991 Oct; 198(1):649-55. PubMed ID: 1716370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modified Arg-Asp-Val (RDV) peptide derived during the synthesis of Arg-Glu-Asp-Val (REDV), a tetrapeptide derived from an alternatively spliced site in fibronectin, inhibits the binding of fibrinogen, fibronectin, von Willebrand factor and vitronectin to activated platelets.
    Chen CS; Papayannopoulos IA; Timmons S; Chou SH; Thiagarajan P
    Biochim Biophys Acta; 1991 Oct; 1075(3):237-47. PubMed ID: 1720019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competition for related but nonidentical binding sites on the glycoprotein IIb-IIIa complex by peptides derived from platelet adhesive proteins.
    Santoro SA; Lawing WJ
    Cell; 1987 Mar; 48(5):867-73. PubMed ID: 3493077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fibrinogen binding to GP IIb-IIIa by a GP IIIa peptide.
    Charo IF; Nannizzi L; Phillips DR; Hsu MA; Scarborough RM
    J Biol Chem; 1991 Jan; 266(3):1415-21. PubMed ID: 1703149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptides and monoclonal antibodies which bind to platelet glycoproteins IIb and/or IIIa inhibit clot retraction.
    Gartner TK; Ogilvie ML
    Thromb Res; 1988 Jan; 49(1):43-53. PubMed ID: 3347927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of ligand binding to glycoprotein IIb-IIIa (integrin alpha IIb beta 3) in isolated platelet membranes.
    Smyth SS; Parise LV
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):749-58. PubMed ID: 7686366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets.
    Savage B; Ruggeri ZM
    J Biol Chem; 1991 Jun; 266(17):11227-33. PubMed ID: 2040630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine-glycine-aspartic acid- and fibrinogen gamma-chain carboxyterminal peptides inhibit platelet adherence to arterial subendothelium at high wall shear rates. An effect dissociable from interference with adhesive protein binding.
    Lawrence JB; Kramer WS; McKeown LP; Williams SB; Gralnick HR
    J Clin Invest; 1990 Nov; 86(5):1715-22. PubMed ID: 2243140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
    Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies on the topography of human platelet glycoprotein IIb. Localization of monoclonal antibody epitopes and the putative glycoprotein IIa- and fibrinogen-binding regions.
    Calvete JJ; Arias J; Alvarez MV; Lopez MM; Henschen A; Gonzalez-Rodriguez J
    Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):767-75. PubMed ID: 1705115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrafibricin has a high selectivity for GPIIb/IIIa: comparison of the effects of tetrafibricin and RGDS on GPIIb/IIIa and the vitronectin receptor.
    Satoh T; Kouns WC; Yamashita Y; Kamiyama T; Steiner B
    Biochem Biophys Res Commun; 1994 Oct; 204(1):325-32. PubMed ID: 7524499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How vitronectin binds to activated glycoprotein IIb-IIIa complex and its function in platelet aggregation.
    Mohri H; Ohkubo T
    Am J Clin Pathol; 1991 Nov; 96(5):605-9. PubMed ID: 1719797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
    Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
    J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ATP on ligand recognition of platelet fibrinogen receptor on GPIIb-IIIa.
    Gawaz MP; Mayinger P; Neumann FJ
    Am J Physiol; 1994 Sep; 267(3 Pt 2):H1098-106. PubMed ID: 8092274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
    Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
    J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Asp-carboxylate of RGDX mimetics and the platelet GP IIb-IIIa receptor.
    Zablocki JA; Miyano M; Rao SN; Panzer-Knodle S; Nicholson N; Feigen L
    J Med Chem; 1992 Dec; 35(26):4914-7. PubMed ID: 1479591
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of hybrid peptide analogs to receptor recognition domains on alpha- and gamma-chains of human fibrinogen on fibrinogen binding to platelets.
    Mohri H; Ohkubo T
    Thromb Haemost; 1993 May; 69(5):490-5. PubMed ID: 8322271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.